Cargando…

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients

Mostrar otras versiones (1)

OBJECTIVE: To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. DESIGN: Retrospective observational and analytical cohort study. SETTING: COVID-19 patients admitted to the intensive care unit of a tertiary hospital between Marc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabara, C., Solarat, B., Castro, P., Fernández, S., Badia, J.R., Toapanta, D., Schulman, S., Reverter, J.C., Soriano, A., Moisés, J., Aibar, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier España, S.L.U. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321771/ http://dx.doi.org/10.1016/j.medin.2021.07.004

Ejemplares similares

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
por: Gabara, C., et al.
Publicado: (2023)

ANTICOAGULATION, BLEEDING, AND IMMUNOTHROMBOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: PAEZ VARGAS, JUAN, et al.
Publicado: (2021)

Management of acute renal replacement therapy in critically ill cirrhotic patients
por: Del Risco-Zevallos, Jimena, et al.
Publicado: (2022)

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study
por: Tafur, Alfonso J., et al.
Publicado: (2020)

Epidemiology of Bleeding in Critically Ill Children
por: Sequeira, Jake, et al.
Publicado: (2021)

Severe acute kidney injury in critically ill COVID-19 patients
por: Piñeiro, Gaston J., et al.
Publicado: (2021)

Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study
por: Leighl, N B, et al.
Publicado: (2011)

Gastrointestinal bleeding in critically ill immunocompromised patients
por: Catano, Jennifer, et al.
Publicado: (2021)

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events
por: de Winter, R. J.
Publicado: (2018)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Beneficial use of predilution in reducing the amount of anticoagulation and the occurrence of bleeding during CRRT in critically ill patients: a prospective randomized study
por: Honoré, PM, et al.
Publicado: (1998)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Incidence & outcomes of clinically significant bleeding events in critically ill COVID-19 patients receiving Therapeutic dose AntiCoagulanTs: A retrospective cohort study (INTerACT study)
por: Singh, Ajay, et al.
Publicado: (2022)

Bleeding complications in critically ill patients with liver cirrhosis
por: Cho, Jaeyoung, et al.
Publicado: (2016)

Adrenocortical function and outcome in critically ill patients
por: Bermejo, E, et al.
Publicado: (1998)

Empiric Anticoagulation Therapy in Hospitalized COVID-19 Patients: An Evaluation of Bleeding Risk Scores Performances in Predicting Bleeding Events
por: Abdelrahman, Mona A., et al.
Publicado: (2022)

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Publicado: (2021)

CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)

Concurrent use of Chinese herbal medicine and anticoagulants may reduce major bleeding events
por: Hsu, Shuo-Min, et al.
Publicado: (2022)

Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection
por: Fernandez, Javier, et al.
Publicado: (2020)

Timing and incidence density of upper gastrointestinal bleeding acquired by critically ill children
por: Chaïbou, M, et al.
Publicado: (2000)

Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
por: Proietti, Marco, et al.
Publicado: (2018)

Understanding Bleeding Risk after Anticoagulation
Publicado: (2005)

Urgent orotracheal intubation in critically ill patients
por: Bernal, M Hernández, et al.
Publicado: (2011)

Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis
por: Valade, Sandrine, et al.
Publicado: (2015)

Epidemiology of Bleeding in Critically Ill Children With an Underlying Oncologic Diagnosis
por: Romano, Juliana, et al.
Publicado: (2021)

Physiologic approach to red blood cell transfusion in non-bleeding critically ill patients
por: Czempik, Piotr F., et al.
Publicado: (2022)

Measuring the anticoagulant effect of low molecular weight heparins in the critically ill
por: Crowther, Mark, et al.
Publicado: (2006)

COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
por: Paez Vargas, Juan José, et al.
Publicado: (2021)

Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation
por: Ramadori, Giuliano
Publicado: (2021)

Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis
por: Maura, Géric, et al.
Publicado: (2018)

Anticoagulation status post radiofrequency ablation in a patient with hepatocellular carcinoma and delayed bleeding event
por: Adaramola, Oladapo, et al.
Publicado: (2020)

Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics
por: Yagi, Tatsuya, et al.
Publicado: (2022)

Evaluation of Patient Characteristics Linked to Major Bleeding Events in Patients Prescribed Direct Oral Anticoagulants
por: Kanaan, Dareen M., et al.
Publicado: (2023)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Root cause analysis of hypoglycemic events in critically ill patients
por: McDonald, A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_400jirbhkp06jh3q03hmebdbfb